TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Mar 3, 7:12 AM ET

Griffin Deborah A 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 3, 2020

Insider Transaction Report

Form 4
Period: 2020-02-28
Griffin Deborah A
Chief Accounting Officer
Transactions
  • Award

    Restricted Share Units

    2020-02-28+21,45921,459 total
    Ordinary Shares (21,459 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on February 28, 2020 with 5,364 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 5,367 vesting on February 28, 2024.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION